VectorBuilder Announces Highly Stable MuteFree™ AAV for Gene Therapy
NQ Score
84/100
N1 Content Completeness
9
AI Summary (NQ-processed)
VectorBuilder has developed the MuteFree™ AAV vector to solve ITR sequence instability in gene therapy manufacturing. This technology reduces the mutation rate to 0% using standard E. coli, significantly improving viral yield and reliability.